WallStSmart

Silynxcom Ltd. (SYNX)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 4213% more annual revenue ($258.90M vs $6.00M). ZEPP leads profitability with a -15.5% profit margin vs -54.8%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

SYNX

Avoid

26

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -1.69

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

SYNXUndervalued (+75.4%)

Margin of Safety

+75.4%

Fair Value

$4.19

Current Price

$1.32

$2.87 discount

UndervaluedFair: $4.19Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SYNX2 strengths · Avg: 9.5/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.169/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

SYNX4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$8.43M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-49.7%2/10

ROE of -49.7% — below average capital efficiency

Revenue GrowthGrowth
-57.7%2/10

Revenue declined 57.7%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : SYNX

The strongest argument for SYNX centers on Price/Book, Debt/Equity.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : SYNX

The primary concerns for SYNX are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

SYNX profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor COMMUNICATION EQUIPMENT industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 26/100) and 43.0% revenue growth. SYNX offers better value entry with a 75.4% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Silynxcom Ltd.

TECHNOLOGY · COMMUNICATION EQUIPMENT · USA

Silynxcom Ltd. (SYNX) is a leading innovator in the defense communication sector, specializing in the development of cutting-edge audio and electronic systems tailored for military and law enforcement applications. The company prioritizes enhancing interoperability and situational awareness through advanced technologies that address the complex needs of its clientele. With a robust commitment to research and development, SYNX delivers high-performance products designed to thrive in critical operational environments. Positioned to capitalize on increased global defense expenditures, Silynxcom is strategically aligned to meet the growing demand for secure, reliable communication solutions in defense.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?